Crossref
Research on the Strategy for Waiving Bioequivalence of Transdermal Preparations
Pharmacy Information · 2026 · 15 (03) · 234-242
DOI: 10.12677/pi.2026.153026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacy Information, 2026. Verfasst von 晓斌 段. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
段, 晓. (2026). Research on the Strategy for Waiving Bioequivalence of Transdermal Preparations. Pharmacy Information, 15(03), 234-242. https://doi.org/10.12677/pi.2026.153026
Vancouver
段 晓. Research on the Strategy for Waiving Bioequivalence of Transdermal Preparations. Pharmacy Information. 2026;15(03):234-242. doi:10.12677/pi.2026.153026
BibTeX
@article{2026,
author = {段, 晓斌},
title = {Research on the Strategy for Waiving Bioequivalence of Transdermal Preparations},
journal = {Pharmacy Information},
year = {2026},
volume = {15},
number = {03},
pages = {234--242},
doi = {10.12677/pi.2026.153026}
}
EUVIMED